Variant-adapted COVID-19 booster vaccines

Florian Krammer^{1

2

3}, Ali H Ellebedy^{4

5}

Affiliations

¹ Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
² Center for Vaccine Research and Pandemic Preparedness (C-VaRPP), Icahn School of Medicine at Mount Sinai, New York, NY, USA.
³ Department of Pathology, Molecular and Cell Based Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
⁴ Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO, USA.
⁵ Center for Vaccines and Immunity to Microbial Pathogens, Washington University School of Medicine, St. Louis, MO, USA.

Florian Krammer et al. Science. 2023.

. 2023 Oct 13;382(6667):157-159.

doi: 10.1126/science.adh2712. Epub 2023 Oct 12.

Florian Krammer^{1

2

3}, Ali H Ellebedy^{4

5}

¹ Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
² Center for Vaccine Research and Pandemic Preparedness (C-VaRPP), Icahn School of Medicine at Mount Sinai, New York, NY, USA.
³ Department of Pathology, Molecular and Cell Based Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
⁴ Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO, USA.
⁵ Center for Vaccines and Immunity to Microbial Pathogens, Washington University School of Medicine, St. Louis, MO, USA.

Abstract

Current vaccines should be tailored to combat future SARS-CoV-2 variants.